Bristol-Myers Squibb

Route 206 & Province Line Road
08543 Princeton, New Jersey
US

Contact WebSite

Article

Bristol Myers Squibb Acquires RayzeBio
28.12.2023 • News

Bristol Myers Squibb Acquires RayzeBio

Bristol Myers Squibb will acquire RayzeBio for a total equity value of approximately $4.1 billion, or $3.6 billion net of estimated cash acquired. The transaction was unanimously approved by both the Bristol Myers Squibb and RayzeBio Boards of Directors.

Bristol Myers Squibb Takes Over Karuna Therapeutics
23.12.2023 • News

Bristol Myers Squibb Takes Over Karuna Therapeutics

Bristol Myers Squibb (BMS) and Karuna Therapeutics have entered into a definitive merger agreement under which the US drug maker has agreed to acquire the Boston-based biopharmaceutical company for a total equity value of $14.0 billion, or $12.7 billion net of estimated cash acquired. The transaction was unanimously approved by both the BMS and Karuna Boards of Directors.